Vita 34 AG, DE000A0BL849

Vita 34 AG, DE000A0BL849

27.06.2017 - 07:32:19

Vita 34 AG signs cooperation agreement with Romanian company Besmax Life Solutions SRL

Vita 34 AG signs cooperation agreement with Romanian company Besmax Life Solutions SRL

- Vita 34 to expand market access in Romania

- Size of total Romanian market comparable to Germany

Leipzig, June 27, 2017 - Vita 34 AG (ISIN: DE000A0BL849; WKN: A0BL84), the second largest stem cell bank in Europe, has entered into a cooperation agreement with the Romanian company Besmax Life Solutions SRL. The long-term partnership is aimed at achieving a relevant market share in the Romanian market. The Romanian market for storages of umbilical cord blood has a total volume of EUR 14 million, roughly equivalent to the German market.

Besmax Life Solutions SRL focuses on stem cells. The company is part of the Life Solutions Group, whose healthcare companies operate in specialty pharmaceutical sales, among other fields. This includes blood reserves, plasma and vaccines for various medical disciplines including gynecology and obstetrics. The partnership therefore offers clear access to childbirth clinics. This is a necessary step to building an efficient logistics network, not only to reach potential customers, but also for the extraction and processing of umbilical cord blood and tissue. In accordance with the cooperation agreement, the production of stem cell preparations from samples taken and cryopreservation are to be carried out at Vita 34 AG in Leipzig.

"Expanding market access in Romania is an important step in the continuation of our buy and build strategy. Our market research has shown that a relatively high demand exists in Romania. We attribute this to the strong self-sufficiency of the families within the country's health system. A strong and established sales partner enables us to address these needs at a high quality level that is 'Made in Germany'," commented Dr. Wolfgang Knirsch, Chairman of the Management Board of Vita 34 AG.

Company profiles

Vita 34 was founded in 1997 as the first private umbilical cord blood bank in Europe and, as a complete provider, offers collection logistics, preparation and storage of umbilical cord blood and cord tissue. The basis for its successful work is an outstanding position in the technological segment of cryo-preservation. Here, cells and tissue are preserved alive at some -190ºC for long periods of time, and can be used if needed in the context of medical treatment. Some 160,000 families are already taking advantage of this offering and have provided for their children with a stem cell deposit at Vita 34.

Besmax Life Solutions SRL is a Romanian company that is part of the Life Solutions Group, which specializes in stem cells. The Life Solutions Group is a group of healthcare companies that market pharmaceutical products, medical equipment and devices. Among other areas, the group is an important supplier of human blood and plasma products such as immunoglobulins, human albumin and coagulation factors. The company's portfolio also includes specialty pharmaceuticals for obstetrics and gynecology, general surgery, transplantation (organs and tissues), hematology and oncology.

27.06.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English

Company: Vita 34 AG Deutscher Platz 5a 04103 Leipzig

Germany Phone: +49(0341)48792-40 Fax: +49(0341)48792-39 E-mail: ir@vita34.de Internet: www.vita34.de ISIN: DE000A0BL849 WKN: A0BL84 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange   End of News DGAP News Service

586395  27.06.2017 

@ dgap.de